RCT of Mobile Apps & FitBit v. Usual Care

Running, not enrolling · Not applicable

Conditions studied: Pancreatic Cancer, Gastric Cancer, Hepatic Cancer, Colon Cancer, Rectal Cancer, Small Bowel Cancer

In brief

This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.

Key facts

Study ID

NCT03623464

Run by

Weill Medical College of Cornell University

People needed

107

Starts

2017-05-31

Expected to finish

2026-06-01

Last updated by the study team

2025-12-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject is 18 years or older
• Subject speaks English
• Subject owns a smart phone
• Subject is scheduled to undergo surgery for a GI cancer (pancreatic, hepatic, gastric, small bowel, colon, or rectal cancers)

You may not qualify if…

• Physician deems the subject is unable to complete the study due to documented dementia
• Subject is undergoing emergent surgery
• Subject has sepsis from another source
• Physician deems the subject is unable to complete the study due to documented alcohol and/or drug abuse

Where it is running

• Weill Cornell Medicine- New York Presbyterian — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.